Research Supports Marijuana Reform Push in the U.S.
The business of marijuana sales in the U.S. continues to grow in 2015 and is expected to surpass the billion dollar earnings mark in 2015. 4 states have passed legislation that allows recreational marijuana use and 23 states have passed legislation that permits medical marijuana use. Other states and cities are scheduled to consider marijuana reform law as 2016 gets under way. More research needs to be done to verify the benefits of medical marijuana, but some research is currently available already. The Journal of the American Medical Association presented a summary of research to show that marijuana can be used to treat chronic pain conditions in patients, which is a positive outcome for veteran patients specifically. This review of research came out this year and supports the push to reform marijuana law in the U.S. Even the Veteran’s Affairs website reports on the use of medical marijuana. Veteran’s and other patients dealing with conditions of chronic pain, brain injury, and Post Traumatic Stress Disorder hope that policy makers around the nation review the positive findings in the Journal of the American Medical Association regarding medical marijuana.
Medical Marijuana News Conclusions from the Journal of the American Medical Association:
According to the analysis posted in the Journal of the American Medical Association, a moderate level of evidence supports the use of cannabinoids for treating chronic pain conditions in patients. The study that was published in the June 23/30 issue of the journal analyzed 79 randomized trials that included over 6,400 patients. The lead author was Penny Whiting, Ph.D. of the University of Bristol. Penny completed a meta-analysis of the evidence from these trials to glean the benefits, yet also negative outcomes, linked to using medical cannabinoids. In general, the research found that most use of medical cannabinoids resulted in the patients reporting positive outcomes regarding their symptoms, yet the benefits were not statistically significant in all of the studies.
Overall, the analysis revealed that medical cannabinoids can be effective in dealing with chronic pain. The study also revealed that medical cannabinoids can be effective when used to treat sleep disorders, treating spasticity due to multiple sclerosis, stimulating appetite for weight gain, as well as low level improvement with anxiety symptoms.
In conclusion, Penny and colleagues relayed that additional, more robust and comprehensive, studies need to be conducted on the effectiveness of medical marijuana in patients. This will not likely happen as comprehensively as it should until the federal government removes marijuana from the list of Schedule 1 drugs.